Prevalence of depression in adults with cancer: A systematic review

Annals of Oncology

Volumn 24, Issue 4, 2013, Pages 895-900

  Walker, J ^a   Holm Hansen, C ^b   Martin, P ^b   Sawhney, A ^b   Thekkumpurath, P ^b   Beale, C ^b   Symeonides, S ^c   Wall, L ^c   Murray, G ^b   Sharpe, M ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Cancer; Depression; Prevalence; Review; Systematic

Indexed keywords

ARTICLE; CANCER PALLIATIVE THERAPY; CANCER PATIENT; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HOSPITAL PATIENT; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; OUTPATIENT; PREVALENCE; PRIORITY JOURNAL; PSYCHIATRIST; PSYCHOLOGIST; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; SYSTEMATIC REVIEW;

ADULT; AGED; COST-BENEFIT ANALYSIS; DEPRESSION; FEMALE; HUMANS; MALE; NEOPLASMS; PREVALENCE; QUALITY OF LIFE;

EID: 84875591993     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mds575     Document Type: Article

References (53)

1. Ustun TB, Ayuso-Mateos JL, Chatterji S et al Global burden of depressive disorders in the year 2000. Br J Psychiatry 2004; 184: 386-392.
2. Moussavi S, Chatterji S, Verdes E et al Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 2007; 370 (9590): 851-858.
3. Colleoni M, Mandala M, Peruzzotti G et al Depression and degree of acceptance of adjuvant cytotoxic drugs. Lancet 2000; 356(9238): 1326-1327.
4. Sharpe M, Strong V, Allen K et al Major depression in outpatients attending a regional cancer centre: screening and unmet treatment needs. Br J Cancer 2004; 90(2): 314-320.
5. Fallowfield L, Ratcliffe D, Jenkins V et al Psychiatric morbidity and its recognition by doctors in patients with cancer. Br J Cancer 2001; 84(8): 1011-1015.
6. Fann JR, Berry DL, Wolpin S et al Depression screening using the Patient Health Questionnaire-9 administered on a touch screen computer. Psycho-Oncology 2009; 18(1): 14-22.
7. Kissane DW, Bultz B, Butow PN et al (eds). Handbook of Communication in Oncology and Palliative Care. Oxford: Oxford University Press 2011.
8. Walker J, Sharpe M. Depression care for people with cancer: a collaborative care intervention. Gen Hosp Psychiatry 2009; 31(5): 436-441.
9. Strong V, Waters R, Hibberd C et al Management of depression for people with cancer (SMaRT oncology 1): a randomised trial. Lancet 2008; 372(9632): 40-48.
10. Mitchell AJ, Chan M, Bhatti H et al Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol 2011; 12(2): 160-174.
11. Massie MJ. Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr 2004; 32: 57-71.
12. Fann JR, Thomas-Rich AM, Katon WJ et al Major depression after breast cancer: a review of epidemiology and treatment. Gen Hosp Psychiatry 2008; 30(2): 112-126.
13. Archer J, Hutchison I, Korszun A. Mood and malignancy: head and neck cancer and depression. J Oral Pathol Med 2008; 37(5): 255-270.
14. Caplette-Gingras A, Savard J. Depression in women with metastatic breast cancer: a review of the literature. Palliat Support Care 2008; 6(4): 377-387.
15. Hotopf M, Chidgey J, Addington-Hall J et al Depression in advanced disease: a systematic review. Part 1. Prevalence and case finding. Palliat Med 2002; 16(2): 81-97.
16. Reich M, Lesur A, Perdrizet-Chevallier C. Depression, quality of life and breast cancer: a review of the literature. Breast Cancer Res Treat 2008; 110(1): 9-17.
17. Sellick SM, Crooks DL. Depression and cancer: an appraisal of the literature for prevalence, detection, and practice guideline development for psychological interventions. Psychooncology 1999; 8(4): 315-333.
18. van't Spijker A, Trijsburg RW, Duivenvoorden HJ. Psychological sequelae of cancer diagnosis: a meta-analytical review of 58 studies after 1980. Psychosom Med 1997; 59(3): 280-293.
19. Thompson DS, Shear MK. Psychiatric disorders and gynecological oncology: a review of the literature. Gen Hosp Psychiatry 1998; 20(4): 241-247.
20. Lydiatt WM, Moran J, Burke WJ. A review of depression in the head and neck cancer patient. Clin Adv Hematol Oncol 2009; 7(6): 397-403.
21. Kasparian NA, McLoone JK, Butow PN. Psychological responses and coping strategies among patients with malignant melanoma: a systematic review of the literature. Arch Dermatol 2009; 145(12): 1415-1427.
22. Singer S, Das-Munshi J, Brahler E. Prevalence of mental health conditions in cancer patients in acute care - a meta-analysis. Ann Oncol 2010; 21: 925-930.
23. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edition. Washington, DC: American Psychiatric Association 1994.
24. World Health Organization. International Classification of Mental and Behavioural Disorders (ICD-10). Geneva, Switzerland: World Health Organization 1992.
25. Mallen C, Peat G, Croft P. Quality assessment of observational studies is not commonplace in systematic reviews. J Clin Epidemiol 2006; 59(8): 765-769.
26. Loney PL, Chambers LW, Bennett KJ et al Critical appraisal of the health research literature: prevalence or incidence of a health problem. Chronic Dis Can 1998; 19(4): 170-176.
27. Berlin JA, Rennie D. Measuring the quality of trials: the quality of quality scales. JAMA 1999; 282(11): 1083-1085.
28. Juni P, Witschi A, Bloch R et al The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 1999; 282(11): 1054-1060.
29. Naing L, Winn T, Rusli BN. Practical issues in calculating the sample size for prevalence studies. Arch Orofacial Sci 2006; 1: 9-14.
30. Coyne JC, Palmer SC, Shapiro PJ et al Distress, psychiatric morbidity, and prescriptions for psychotropic medication in a breast cancer waiting room sample. Gen Hosp Psychiatry 2004; 26: 121-128.
31. Gandubert C, Carriere I, Escot C et al Onset and relapse of psychiatric disorders following early breast cancer: a case-control study. Psycho-Oncology 2009; 18 (10): 1029-1037.
32. Grassi L, Malacarne P, Maestri A et al Depression, psychosocial variables and occurrence of life events among patients with cancer. J Affect Disord 1997; 44 (1): 21-30.
33. Leopold KA, Ahles TA, Walch S et al Prevalence of mood disorders and utility of the PRIME-MD in patients undergoing radiation therapy. Int J Radiat Oncol Biol Phys 1998; 42(5): 1105-1112.
34. Uchitomi Y, Mikami I, Kugaya A et al Depression after successful treatment for nonsmall cell lung carcinoma - a 3-month follow-up study. Cancer 2000; 89(5): 1172-1179.
35. Atesci FC, Baltalarli B, Oguzhanoglu NK et al Psychiatric morbidity among cancer patients and awareness of illness. Support Care Cancer 2004; 12: 161-167.
36. Kugaya A, Akechi T, Okuyama T et al Prevalence, predictive factors, and screening for psychologic distress in patients with newly diagnosed head and neck cancer. Cancer 2000; 88(12): 2817-2823.
37. Nuhu FT, Odejide OA, Adebayo KO et al Prevalence and predictors of depression in cancer patients in the University College Hospital Ibadan, Nigeria. Hong Kong J Psychiatry 2008; 18(3): 107-114.
38. Akechi T, Okamura H, Nishiwaki Y et al Psychiatric disorders and associated and predictive factors in patients with unresectable nonsmall cell lung carcinoma: a longitudinal study. Cancer 2001; 92(10): 2609-2622.
39. Atesci FC, Oguzhanoglu NK, Baltalarli B et al Psychiatric disorders in cancer patients and associated factors. Turk J Psychiatry 2003; 14(2): 145-152.
40. Derogatis LR, Morrow GR, Fetting J et al The prevalence of psychiatric disorders among cancer patients. JAMA 1983; 249(6): 751-757.
41. Akechi T, Okuyama T, Sugawara Y et al Major depression, adjustment disorders, and post-traumatic stress disorder in terminally ill cancer patients: associated and predictive factors. J Clin Oncol 2004; 22(10): 1957-1965.
42. Ciaramella A, Poli P. Assessment of depression among cancer patients: the role of pain, cancer type and treatment. Psycho-Oncology 2001; 10(2): 156-165.
43. Lloyd-Williams M, Friedman T, Rudd N. An analysis of the validity of the Hospital Anxiety and Depression scale as a screening tool in patients with advanced metastatic cancer. J Pain Symptom Manage 2001; 22(6): 990-996.
44. Von Elm E, Altman DG, Egger M et al Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 2007; 335(7624): 806-808.
45. Endicott J. Measurement of depression in patients with cancer. Cancer 1984; 53: 2243-2249.
46. First MB, Gibbon M, Spitzer RL et al User's Guide for the SCID-I, Structured Clinical Interview for DSM-IV Axis I Disorders, research version. New York, NY: Biometrics Research Department, New York State Psychiatric Institute 1996.
47. Wasteson E. Mood disorders in patients with cancer. Lancet Oncol 2011; 12(2): 114-115.
48. Simon GE, von Korff M. Medical co-morbidity and validity of DSM-IV depression criteria. Psychol Med 2006; 36(1): 27-36.
49. Chochinov HM, Wilson KG, Enns M et al Prevalence of depression in the terminally ill - effects of diagnostic-criteria and symptom threshold judgments. Am J Psychiatry 1994; 151(4): 537-540.
50. Wasteson E, Brenne E, Higginson IJ et al Depression assessment and classification in palliative cancer patients: a systematic literature review. Palliat Med 2009; 23(8): 739-753.
51. Stroup DF, Berlin JA, Morton SC et al for the Meta-analysis of Observational Studies in Epidemiology (MOOSE) Group. Meta-analysis of observational studies in epidemiology. A proposal for reporting. JAMA 2000; 283: 2008-2012.
52. Moher D, Liberati A, Tetzlaff J et al Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009; 339: b2535.
53. DiMatteo MR, Haskard-Zolnierek KB. Impact of depression on treatment adherence and survival from cancer. In Kissane DW, Maj M, Sartorius N (eds), Depression and Cancer. Chichester: Wiley-Blackwell 2011.